Scientists launch new trial for long COVID treatment
S1: Welcome in San Diego. It's Jade Hindman. On today's show , we'll tell you about the new research being done on GLP one's impact on long Covid. This is KPBS Midday Edition. Connecting our communities through conversation. Welcome back to KPBS Midday Edition I'm Jade Hindman. Last week , scientists at Scripps Research launched a new treatment trial looking to address long Covid , known as Lockett. The trial will be entirely remote and test how a FDA approved drug could provide relief for symptoms. Doctor Eric Topol , executive vice president at Scripps Research Translational Institute , is here to talk about the trial and the state of long Covid research today. Doctor Topol , welcome back to the show.S2: Thanks so much for having me join.S1: So , you know , it's always a pleasure to have...










